SCHEMBL2352899

SCHEMBL2352899

CCCCCCCCCCCCC([C]=O)CCCCC

nearest known ligand 0.46

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MAPT P10636 1/20 0.46
GPR84 Q9NQS5 5/20 0.43
FDPS P14324 3/20 0.43
FFAR1 O14842 1/20 0.43
LMNA P02545 1/20 0.42
TSHR P16473 1/20 0.42
THRB P10828 1/20 0.42
DNM1 Q05193 1/20 0.42
LCK P06239 1/20 0.41
PPARD Q03181 1/20 0.41
ZDHHC20 Q5W0Z9 1/20 0.41
ZDHHC2 Q9UIJ5 1/20 0.41
OPRM1 P35372 1/20 0.40
ADH1B P00325 1/20 0.40
ADH1C P00326 1/20 0.40
ADH1A P07327 1/20 0.40
ADH4 P08319 1/20 0.40
ADH7 P40394 1/20 0.40
LAP3 P28838 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9395492 1.00 MAPT (0.46) MAPTGPR84FDPSFFAR1LMNA
SCHEMBL4207652 1.00 MAPT (0.46) MAPTGPR84FDPSFFAR1LMNA
SCHEMBL7167398 1.00 MAPT (0.46) MAPTGPR84FDPSFFAR1LMNA
SCHEMBL8774901 1.00 MAPT (0.46) MAPTGPR84FDPSFFAR1LMNA
SCHEMBL9395418 1.00 MAPT (0.46) MAPTGPR84FDPSFFAR1LMNA
SCHEMBL10477215 1.00 MAPT (0.46) MAPTGPR84FDPSFFAR1LMNA
SCHEMBL9395704 1.00 MAPT (0.46) MAPTGPR84FDPSFFAR1LMNA
SCHEMBL9714347 1.00 MAPT (0.46) MAPTGPR84FDPSFFAR1LMNA
SCHEMBL5177435 1.00 MAPT (0.46) MAPTGPR84FDPSFFAR1LMNA
SCHEMBL9395395 1.00 MAPT (0.46) MAPTGPR84FDPSFFAR1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011083481-A2 METHOD FOR TREATMENT OF INFLAMMATORY DISEASE AND DISORDER HEALOR LTD. (IL) 2011-07-14 WO disclosed
US-6852686-B2 Methods for ameliorating icthyosiform skin diseases THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2005-02-08 US disclosed
US-20030072795-A1 Methods for ameliorating icthyosiform skin diseases GOVERNMENT OF THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, THE 2003-04-17 US disclosed